Webinar: Why Patient-Specific Insulin Dosing Matters. Watch for free today!
Blog
EndoTool SubQ: What You Should Know
Monarch Medical Technologies EndoTool SubQ provides clinical decision support for any situation where subcutaneous insulin is administered to all patient types, including pediatrics. This proprietary technology models, predicts and adjusts to each patient’s unique physiology and individual response to insulin.
- EndoTool will always recommend the safest, most effective patient-specific dose, beginning with the correct total daily dose and following with the precise recommended basal/bolus dose. How? EndoTool SubQ takes all factors that impact insulin response into account, including: blood glucose level, height, weight, type of diabetes mellitus, age, sex, creatinine levels, steroids, carbohydrate intake and ordered insulin.
- If a patient has low or consistently high readings, EndoTool will adjust accordingly, resulting in the reduction and elimination of correctional dosing.
- The software focuses on the most efficient and effective clinical workflow and promotes mealtime dosing in order to reduce cycling. If needed, EndoTool SubQ can accommodate another workflow, such as having to wait for the verification of carb intake.
- If at any time the nurse is concerned with the amount of insulin given due to a patient not eating as expected, the nurse may enter a new glucose. Based on the new glucose, EndoTool SubQ will recommend supplemental carbohydrates if needed.
- In the case of a patient receiving a low reading after a meal because they didn’t eat or is vomiting, EndoTool SubQ is the only platform where the algorithm will rapidly remodel and suggest additional carb recommendations prior to any hypoglycemic (BG <70 mg/dL) events.
EndoTool SubQ is changing the way we dose insulin in order to achieve better outcomes for our patients. This software provides caretakers the confidence in treating hyperglycemia while preventing hypoglycemia for an overall safer standard of care.
Related posts

Blog
Tackling Euglycemic DKA: How EndoTool’s New Mode of Therapy Gives Hospitals a Critical Advantage
Tackling Euglycemic DKA: How EndoTool’s New Mode of Therapy Gives Hospitals a Critical Advantage
Hyperglycemic emergencies are becoming increasingly complex to treat, particularly with the rising incidence of Euglycemic Diabetic Ketoacidosis (EuDKA). Often linked to the use of SGLT-2 inhibitors, EuDKA requires a treatment approach that traditional diabetic ketoacidosis (DKA) protocols were not designed ...

Blog
Celebrating Our 2025 Customer of the Year: Atrium Health
Celebrating Our 2025 Customer of the Year: Atrium Health
One of the things I value most as CEO is working with partners who share our passion for making a genuine difference in patient care. This year, I'm proud to share that our inaugural Customer of the Year is Atrium ...

Blog
5 Things Every CNO Should Know About Patient-Specific Insulin Dosing
5 Things Every CNO Should Know About Patient-Specific Insulin Dosing
As a former Director of Nursing and now the leader of a national team focused on implementing a clinical decision support tool for glycemic management, I have had the unique opportunity to guide health systems through the operational and clinical ...
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields